Patrick Soon-Shiong,Shahrooz Rabizadeh,Kayvan Niazi
申请号：
US16060020
公开号：
US20180363005A1
申请日:
2016.12.07
申请国别(地区):
US
年份:
2018
代理人:
摘要：
Cancer immunotherapy is enhanced by co-expression of cancer associated or tumor-specific (neo)epitopes with co-stimulatory molecules and/or other immune activators. Where desired, treatment may be enhanced by administration of a immune checkpoint inhibitor.
